Physician profile
Christopher Rathfoot
NPI 1497839757
$3,230.46
in general payments reported to CMS, 2019-2025
25 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $39.22 · 2021: $385 · 2022: $376 · 2023: $491 · 2024: $816 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580 · Travel and Lodging: $218 · Consulting Fee: $100 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.26 |
| Travel and Lodging | $217.56 |
| Consulting Fee | $100.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $692.34 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $523.77 | 2021-2025 | Nucala |
| Stryker Corporation | $294.31 | 2019-2022 | |
| Genzyme Corporation | $270.15 | 2022-2025 | |
| Aerin Medical INC. | $267.25 | 2019-2025 | |
| Genentech USA, INC. | $238.11 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $181.33 | 2019-2025 | Dupixent, Libtayo |
| Medtronic, INC. | $170.00 | 2022-2023 | Straightshot |
| Sun Pharmaceutical Industries INC. | $76.57 | 2019-2022 | |
| Livanova USA, INC. | $69.87 | 2019 | |
| Acera Surgical, INC. | $68.95 | 2025 | Restrata Wound Matrix |
| Merck Sharp & Dohme LLC | $66.39 | 2019-2021 | |
| Amgen INC. | $52.12 | 2025 | Tezspire |
| Davol INC. | $37.76 | 2021 | |
| Optinose US, INC. | $34.43 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $30.61 | 2024 | Acclarent Navwire, Acclarent Aera |
| Intersect Ent, INC. | $21.22 | 2022 | |
| Integra Lifesciences Corporation | $20.11 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Astrazeneca Pharmaceuticals LP | $19.15 | 2025 | Tezspire |
| Axogen | $18.54 | 2019 | |
| Covidien LP | $18.22 | 2019 | |
| Smith+Nephew, INC. | $17.04 | 2025 | Ent Sinus |
| Endogastric Solutions, INC | $14.85 | 2023 | Esophyx |
| Kowa Pharmaceuticals America, INC. | $14.60 | 2022 | |
| Olympus America INC. | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rathfoot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.